Ana Blatnik
Ljubljana, Slovenia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Correction: Two recurrent pathogenic/likely pathogenic variants in PALB2 account for half of PALB2 positive families in Slovenia.
Journal: Human genomics
Published: April 30, 2026
ERN GENTURIS cancer surveillance guideline for individuals with PTEN hamartoma tumour syndrome (PHTS).
Journal: European journal of human genetics : EJHG
Published: November 25, 2025
Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.
Journal: BJC reports
Published: November 14, 2025
Hereditary cancer: Germline testing practices across ERN GENTURIS member countries.
Journal: European journal of human genetics : EJHG
Published: October 31, 2025
Analysis of informed consent forms of patients undergoing cancer genetic testing in the era of next-generation sequencing.
Journal: Hereditary cancer in clinical practice
Published: November 15, 2024
Multifocal vascular neoplasm with an EWSR1::NFATC2 gene fusion and progression to epithelioid angiosarcoma - a case report.
Journal: Virchows Archiv : an international journal of pathology
Published: September 04, 2024
The risk of a second primary cancer in PTEN Hamartoma Tumor Syndrome (PHTS).
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: August 12, 2024
Exploring the impact of BRCA1 and BRCA2 mutation type and location on Olaparib maintenance therapy in platinum-sensitive relapsed ovarian Cancer patients: A single center report.
Journal: Gynecologic oncology
Published: July 08, 2024
Last Updated: 09/26/2026